Skip to content

outcome of fetal cardiomyopathies in Japan

outcome of fetal cardiomyopathies in Japan - outcome of fetal cardiomyopathies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026935
Enrollment
100
Registered
2017-04-11
Start date
2017-05-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal cardiomyopathy

Interventions

None listed

Sponsors

Toyama university, pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: fetal cardiomyopathy

Exclusion criteria

Exclusion criteria: bradyarrthythmia due to positive SSA antibody

Design outcomes

Primary

MeasureTime frame
1 years after birth fetal demise/ neonatal death/ servive

Countries

Japan

Contacts

Public Contactsayaka ozawa

Toyama university pediatrics

sozawa34@med.u-toyama.ac.jp076-434-7313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026